Physician profile
Norah E Walsh
NPI 1215945373
$5,066.34
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,237 · 2020: $933 · 2021: $1,661 · 2022: $1,032 · 2023: $36.78 · 2024: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.83 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $812.49 | 2019-2022 | |
| Abbvie INC. | $733.71 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $603.67 | 2019-2023 | |
| Novo Nordisk INC | $542.91 | 2019-2022 | |
| Lilly USA, LLC | $397.66 | 2019-2024 | Jardiance |
| Glaxosmithkline, LLC. | $294.43 | 2019-2022 | |
| Amgen INC. | $267.75 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $187.84 | 2020-2021 | |
| Amarin Pharma, INC. | $178.37 | 2020-2021 | |
| Comsort, INC | $150.00 | 2019 | |
| Corcept Therapeutics | $149.53 | 2020-2022 | |
| Allergan, INC. | $146.23 | 2020 | |
| Abiomed | $113.24 | 2024 | Impella |
| Mylan Specialty L.P. | $94.87 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $63.24 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62.84 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $56.76 | 2021-2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $55.39 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.88 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.78 | 2022 | |
| Astellas Pharma US INC | $16.89 | 2020 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.77 | 2022 | |
| Exact Sciences Corporation | $14.03 | 2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $13.96 | 2019 | |
| Sanofi Pasteur INC. | $12.71 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norah Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.